Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Plotkin

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Pharmacology, Biochemistry, and Behavior|April 28, 2001
Withdrawal from alcohol in withdrawal seizure-prone and -resistant mice: evidence for enkephalin resistanceS R Plotkin, W A Banks, C S Cohn, et al.
Clinical Genetics|March 27, 2009
Identity analysis of schwannomatosis kindreds with recurrent constitutional SMARCB1 (INI1) alterationsM J Smith, C D Boyd, M M MacCollin, et al.
Clinical Genetics|July 24, 2008
Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosisC Boyd, M J Smith, L Kluwe, et al.
Acta Neurologica Scandinavica|September 16, 2015
Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2S Farschtschi, V L Merker, D Wolf, et al.
Neurology|June 16, 2005
Diagnostic criteria for schwannomatosisM MacCollin, E A Chiocca, D G Evans, et al.
American Journal of Medical Genetics. Part A|October 21, 2016
Creation of an international registry to support discovery in schwannomatosisK L Ostrow, A L Bergner, J Blakeley, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Pharmacology, Biochemistry, and Behavior|April 28, 2001
Withdrawal from alcohol in withdrawal seizure-prone and -resistant mice: evidence for enkephalin resistanceS R Plotkin, W A Banks, C S Cohn, et al.
Clinical Genetics|March 27, 2009
Identity analysis of schwannomatosis kindreds with recurrent constitutional SMARCB1 (INI1) alterationsM J Smith, C D Boyd, M M MacCollin, et al.
Clinical Genetics|July 24, 2008
Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosisC Boyd, M J Smith, L Kluwe, et al.
Acta Neurologica Scandinavica|September 16, 2015
Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2S Farschtschi, V L Merker, D Wolf, et al.
Neurology|June 16, 2005
Diagnostic criteria for schwannomatosisM MacCollin, E A Chiocca, D G Evans, et al.
American Journal of Medical Genetics. Part A|October 21, 2016
Creation of an international registry to support discovery in schwannomatosisK L Ostrow, A L Bergner, J Blakeley, et al.
Pageof 2